Cadila Of India To Expand On Being First With H1N1 Flu Vaccine
This article was originally published in PharmAsia News
India's Cadila Healthcare plans to take advantage of being granted the nation's first approval for an H1N1 flu vaccine and expand into other areas
You may also be interested in...
Chugai is pursuing further Japanese litigation over generic rivals to its Edirol brand, this time concerning the eldecalcitol ingredient produced by Nissan Chemical.
The European Commission has unexpectedly concluded that CBD should not be considered as a drug opening up the path to a regulated EU market for the cannabinoid as a novel food.
As Apotex names its new US president and CEO, Akorn puts together a fresh board of directors following bankruptcy proceedings. Stada has made new appointments in Germany, while Siegfried makes significant changes in its leadership roles.